Trial NCT01555281

View at ClinicalTrials.gov 
Org. Study IDs: SAKK 39/10
Secondary IDs: 000001246 2010-022035-11

Last trial update was posted on 2022-07-07

MeSH Interventions

Dexamethasone Lenalidomide Nelfinavir

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

In connection with the restructuring of SAKK, older ongoing studies were analyzed to determine whether a continuation of the trial would still add value to the data analysis, or whether they do not and could therefore be prematurely terminated.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID